RIA
UTHR icon

Regal Investment Advisors’s United Therapeutics UTHR Stock Holding History

Regal Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-795
Closed -$387K – 677
2025
Q4 		$387K Buy
+795
New +$370K 0.02% 466
2019
Q2 		– Sell
-17,200
Closed -$2.02M – 375
2019
Q1 		$2.02M Sell
17,200
-80
-0.5% -$9.32K 0.41% 81
2018
Q4 		$1.88M Sell
17,280
-274
-2% -$31.8K 0.41% 72
2018
Q3 		$2.25M Buy
17,554
+2,596
+17% +$321K 0.47% 61
2018
Q2 		$1.69M Sell
14,958
-2,900
-16% -$319K 0.51% 60
2018
Q1 		$2.01M Buy
+17,858
New +$2.27M 0.44% 68
2015
Q2 		– Sell
-47
Closed -$8K – 1025
2015
Q1 		$8K Hold
47
– – ﹤0.01% 740
2014
Q4 		$6K Sell
47
-128
-73% -$16.5K ﹤0.01% 729
2014
Q3 		$23K Sell
175
-646
-79% -$66.6K 0.01% 533
2014
Q2 		$73K Sell
821
-21,415
-96% -$2.06M 0.03% 324
2014
Q1 		$2.09M Buy
22,236
+3,775
+20% +$386K 0.89% 31
2013
Q4 		$2.09M Buy
18,461
+1,439
+8% +$130K 1.2% 12
2013
Q3 		$1.34M Sell
17,022
-1,940
-10% -$142K 0.78% 30
2013
Q2 		$1.25M Buy
+18,962
New +$1.22M 0.69% 35

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Regal Investment Advisors's UTHR Position: Q1 2026 in Review

Regal Investment Advisors sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 795 shares — an estimated $387K sold.

Regal Investment Advisors first reported a position in UTHR in Q2 2013 and held it in 14 quarters. The position peaked at $2.25M in Q3 2018. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Regal Investment Advisors reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Regal Investment Advisors sold 795 United Therapeutics shares in Q1 2026, an estimated $387K.
  • Regal Investment Advisors first reported a position in United Therapeutics in Q2 2013 and held it in 14 quarters.
  • Regal Investment Advisors's United Therapeutics position peaked at $2.25M in Q3 2018.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.